Vericel earnings were $33.3M for the trailing 12 months ending Sep 30, 2026, with 153.8% growth year over year. The latest VCEL earnings report on Sep 30, 2026 announced Q3 2026 earnings of $14.2M, up 541.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, VCEL reported annual earnings of $16.5M, with 59.4% growth.
VCEL past earnings growth
How has VCEL's earnings growth performed historically?
On VCEL's earnings call on Nov 5, 2026, Vericel (NASDAQ: VCEL) reported Q3 2026 earnings per share (EPS) of $0.28, up 180% year over year. Total VCEL earnings for the quarter were $14.16 million. In the same quarter last year, Vericel's earnings per share (EPS) was $0.10.
As of the last Vericel earnings report, Vericel is currently profitable. Vericel's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $33.31 million, a 154.61% increase year over year.
What was VCEL's earnings growth in the past year?
As of Vericel's earnings date in Nov 5, 2026, Vericel's earnings has grown 153.85% year over year. This is 79.51 percentage points higher than the US Biotechnology industry earnings growth rate of 74.33%. VCEL earnings in the past year totalled $33.31 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.